<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METOLAZONE</span><br/>(me-tole'a-zone)<br/><span class="topboxtradename">Mykrox, </span><span class="topboxtradename">Zaroxolyn <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">electrolytic and water balance agent</span>; <span class="classification">thiazide-like diuretic</span>; <span class="classification">antihypertensive</span><br/><b>Prototype: </b>Hydrochlorothiazide<br/><b>Pregnancy Category: </b>D<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p> 2.5 mg, 5 mg, 10 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Diuretic structurally and pharmacologically similar to hydrochlorothiazide. Diuretic action is associated with drug interference
         with transport of sodium ions across renal tubular epithelium. This enhances excretion of sodium, chloride, potassium, bicarbonate,
         and water.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Produces a decrease in the systolic and diastolic BPs, and reduces edema in CHF and kidney failure patients. Appears to be
         more effective as a diuretic than thiazides in patients with severe kidney failure.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Management of hypertension as sole agent or to enhance effectiveness of other antihypertensives in severe form of hypertension;
         also edema associated with CHF and kidney disease.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Anuria, hypokalemia; hepatic coma or precoma; hypersensitivity to metolazone and sulfonamides; pregnancy (category D), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of gout; allergies; concomitant use of digitalis glycosides; kidney and liver dysfunction.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Edema</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 520 mg/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 0.20.4 mg/kg/d divided q1224h<br/><br/><span class="indicationtitle">Hypertension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2.55 mg/d; (Mykrox) 0.51 mg/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Do not interchange slow availability tablets and rapid availability tablets. They are not equivalent.</li>
<li>Schedule doses to avoid nocturia and interrupted sleep. Give early in a.m. after eating to prevent gastric irritation (if
            given in 2 doses, schedule second dose no later than 3 p.m.).
         </li>
<li>Store at 15°30° C (59°86° F) in tightly closed container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">GI:</span> Cholestatic jaundice. <span class="typehead">Body as a Whole:</span> Vertigo, orthostatic hypotension. <span class="typehead">Hematologic:</span> Venous thrombosis, leukopenia. <span class="typehead">Metabolic:</span> Dehydration, <span class="speceff-common">hypokalemia, hyperuricemia, hyperglycemia.</span>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Amphotericin B</b>, <span class="classification">corticosteroids</span> increase hypokalemic effects; may antagonize hypoglycemic effects of <span class="classification">sulfonylureas</span>, <b>insulin;</b> <b>cholestyramine,</b> <b>colestipol</b> decrease thiazide absorption; intensifies hypoglycemic and hypotensive effects of <b>diazoxide;</b> because of increased potassium and magnesium loss, may cause <b>digoxin</b> toxicity; decreases <b>lithium</b> excretion, increasing its toxicity; <span class="classification">nsaid</span>s may attenuate diuresisincreased risk of <span class="classification">nsaid</span>-induced kidney failure. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Incompletely absorbed; Mykrox has greater absorption. <span class="typehead">Onset:</span> 1 h. <span class="typehead">Peak:</span> 28 h. <span class="typehead">Duration:</span> 1224 h. <span class="typehead">Distribution:</span> Distributed throughout extracellular tissue; concentrates in kidney; crosses placenta; distributed in breast milk. <span class="typehead">Metabolism:</span> Does not appear to be metabolized. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 14 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Anticipate overdosage and adverse reactions in geriatric patients; may be more sensitive to effects of usual adult dose.</li>
<li>Terminate therapy when adverse reactions are moderate to severe.</li>
<li>Expect possible antihypertensive effects in 3 or 4 d, but 34 wk are required for maximum effect.</li>
<li>Lab tests: Determine serum potassium at regular intervals. Prolonged treatment and inadequate potassium intake increase potential
            for hypokalemia (see Appendix F). Periodic plasma glucose and urinalysis determinations.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drink alcohol; it potentiates orthostatic hypotension.</li>
<li>Antihypertensive therapy may require as adjunct a high-potassium, low-sodium, and low-calorie diet.</li>
<li>Include potassium-rich foods in the diet.</li>
<li>Be aware that if hypokalemia develops, dietary potassium supplement of 10002000 mg (2550 mEq) is usually adequate
            treatment.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>